학술논문
The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate
Document Type
Article
Author
Source
In: Blood . (Blood, 15 January 2003, 101(2):655-663)
Subject
Language
English
ISSN
00064971